Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial

Nature Medicine 2026 Open access

Read full text
Authors: Jan-Jaap J. Mellema, Chantal F. Stockem, Cameron Herberts, Samantha K. Cheung, Daniël J. Vis, Bas W. G. van Rhijn, Laura S. Mertens, Thierry N. Boellaard, Maurits L. van Montfoort, Sara Balduzzi, Jeantine M. de Feijter, Johannes C. Mijn
+10 more Shruti Sharma, Adam C. El Naggar, Joost L. Boormans, Martine Franckena, Richard P. Meijer, Juus L Noteboom, Eva E. Schaake, Debbie G. J. Robbrecht, Britt BM Suelmann, Michiel S. van der Heijden
DOI: 10.1038/s41591-026-04271-3
Cited by: 9
References: 25

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Nature Medicine
Publisher
Springer Science and Business Media LLC
Volume
32
Issue
4
Pages
1241–1248
Publication date
27 February 2026
Language
EN